154 related articles for article (PubMed ID: 9933429)
1. Expression of CD30 mRNA, CD30L mRNA and a variant form of CD30 mRNA in restimulated peripheral blood mononuclear cells (PBMC) of patients with helminthic infections resembling a Th2 disease.
Kilwinski J; Berger T; Mpalaskas J; Reuter S; Flick W; Kern P
Clin Exp Immunol; 1999 Jan; 115(1):114-9. PubMed ID: 9933429
[TBL] [Abstract][Full Text] [Related]
2. Study of gene expression of CD30 variant (CD30v) and CD30 ligand (CD30L) in acute leukemia.
Essa EA; El Halim SM; Abo-Elenin A; El Bendary A; Abdou SH; Farag W
Egypt J Immunol; 2007; 14(1):11-20. PubMed ID: 18689277
[TBL] [Abstract][Full Text] [Related]
3. CD30L up-regulates CD30 and IL-4 expression by T cells.
Rossi FM; Degan M; Mazzocut-Zecchin L; Di Francia R; Aldinucci D; Pinto A; Gattei V
FEBS Lett; 2001 Nov; 508(3):418-22. PubMed ID: 11728464
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of CD30 ligand and interleukin 4 (IL-4) receptors by acute myeloid leukaemia blasts is associated with the expansion of IL-4-producing CD30+ normal T cells.
Rossi FM; Degan M; Mazzocco FT; Di Francia R; Aldinucci D; Poletto D; Vellenga E; Pinto A; Gattei V
Br J Haematol; 2002 Apr; 117(1):59-69. PubMed ID: 11918534
[TBL] [Abstract][Full Text] [Related]
5. IL-5 expressed by CD4+ lymphocytes from Echinococcus multilocularis-infected patients.
Jenne L; Kilwinski J; Scheffold W; Kern P
Clin Exp Immunol; 1997 Jul; 109(1):90-7. PubMed ID: 9218830
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis.
Sturm D; Menzel J; Gottstein B; Kern P
Infect Immun; 1995 May; 63(5):1688-97. PubMed ID: 7729873
[TBL] [Abstract][Full Text] [Related]
7. Increased basal production of interleukin-10 by peripheral blood mononuclear cells in human alveolar echinococcosis.
Godot V; Harraga S; Deschaseaux M; Bresson-Hadni S; Gottstein B; Emilie D; Vuitton DA
Eur Cytokine Netw; 1997 Dec; 8(4):401-8. PubMed ID: 9459621
[TBL] [Abstract][Full Text] [Related]
8. Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines.
Gruss HJ; DaSilva N; Hu ZB; Uphoff CC; Goodwin RG; Drexler HG
Leukemia; 1994 Dec; 8(12):2083-94. PubMed ID: 7528856
[TBL] [Abstract][Full Text] [Related]
9. Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease.
Molin D; Fischer M; Xiang Z; Larsson U; Harvima I; Venge P; Nilsson K; Sundström C; Enblad G; Nilsson G
Br J Haematol; 2001 Sep; 114(3):616-23. PubMed ID: 11552987
[TBL] [Abstract][Full Text] [Related]
10. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
Pellegrini P; Berghella AM; Contasta I; Adorno D
Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
[TBL] [Abstract][Full Text] [Related]
11. Activation of HIV expression by CD30 triggering in CD4+ T cells from HIV-infected individuals.
Maggi E; Annunziato F; Manetti R; Biagiotti R; Giudizi MG; Ravina A; Almerigogna F; Boiani N; Alderson M; Romagnani S
Immunity; 1995 Aug; 3(2):251-5. PubMed ID: 7648397
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous CD30 mRNA expression in peripheral blood mononuclear cells from atopic patients with high IgE serum levels.
Esnault S; Benbernou N; Lavaud F; Guenounou M
Clin Exp Immunol; 1996 Oct; 106(1):67-72. PubMed ID: 8870700
[TBL] [Abstract][Full Text] [Related]
13. CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin.
Gattei V; Degan M; Gloghini A; De Iuliis A; Improta S; Rossi FM; Aldinucci D; Perin V; Serraino D; Babare R; Zagonel V; Gruss HJ; Carbone A; Pinto A
Blood; 1997 Mar; 89(6):2048-59. PubMed ID: 9058727
[TBL] [Abstract][Full Text] [Related]
14. T-lymphocyte cytokine mRNA expression in cystic echinococcosis.
Fauser S; Kern P
Acta Trop; 1997 Apr; 64(1-2):35-51. PubMed ID: 9095287
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and characterization of chicken tumor necrosis factor (TNF)-superfamily ligands, CD30L and TNF-related apoptosis inducing ligand (TRAIL).
Abdalla SA; Horiuchi H; Furusawa S; Matsuda H
J Vet Med Sci; 2004 Jun; 66(6):643-50. PubMed ID: 15240938
[TBL] [Abstract][Full Text] [Related]
16. Cytokine gene expression in peripheral blood mononuclear cells (PBMC) from patients with pharmacologically treated cystic echinococcosis.
Riganò R; Profumo E; Buttari B; Teggi A; Siracusano A
Clin Exp Immunol; 1999 Oct; 118(1):95-101. PubMed ID: 10540165
[TBL] [Abstract][Full Text] [Related]
17. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. II. Influence of the HLA B8, DR3, DQ2 haplotype.
Godot V; Harraga S; Beurton I; Tiberghien P; Sarciron E; Gottstein B; Vuitton DA
Clin Exp Immunol; 2000 Sep; 121(3):491-8. PubMed ID: 10971516
[TBL] [Abstract][Full Text] [Related]
18. CD30 ligand in lymphoma patients with CD30+ tumors.
Younes A; Consoli U; Snell V; Clodi K; Kliche KO; Palmer JL; Gruss HJ; Armitage R; Thomas EK; Cabanillas F; Andreeff M
J Clin Oncol; 1997 Nov; 15(11):3355-62. PubMed ID: 9363866
[TBL] [Abstract][Full Text] [Related]
19. Echinococcus multilocularis metacestodes modulate cellular cytokine and chemokine release by peripheral blood mononuclear cells in alveolar echinococcosis patients.
Hübner MP; Manfras BJ; Margos MC; Eiffler D; Hoffmann WH; Schulz-Key H; Kern P; Soboslay PT
Clin Exp Immunol; 2006 Aug; 145(2):243-51. PubMed ID: 16879243
[TBL] [Abstract][Full Text] [Related]
20. Opposite effects of the CD30 ligand are not due to CD30 mutations: results from cDNA cloning and sequence comparison of the CD30 antigen from different sources.
Jung W; Krueger S; Renner C; Gause A; Sahin U; Trümper L; Pfreundschuh M
Mol Immunol; 1994 Dec; 31(17):1329-34. PubMed ID: 7527901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
